Plain-English translation of NCT07572903 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called temporal interference stimulation (a type of non-invasive brain stimulation) to see if it can help reduce movement symptoms in people with Parkinson's disease. Researchers will compare the real stimulation to a placebo (sham) stimulation to understand whether the treatment actually works. The study will also explore how this stimulation affects the brain.
Current medications for Parkinson's disease don't work well for everyone, and some people develop side effects over time. This trial is exploring whether this new stimulation approach could offer another option to help manage the movement difficulties that make daily life challenging for people with Parkinson's.
You likely qualify if…
You likely don't qualify if…
You will visit the research center and be randomly assigned to receive either real brain stimulation or placebo stimulation targeting specific brain areas involved in movement control. Each stimulation session lasts 30 minutes, and you'll be in a "drug-off" state (having stopped your regular Parkinson's medications for at least 12 hours). Researchers will assess your movement symptoms before and after each session and monitor your safety throughout the study.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
China